Author:
Wang Qiyu,Seethapathy Rituvanthikaa,Ouyang Tianqi,Strohbehn Ian A.,Katz-Agranov Nurit,Hanna Paul,Madken Mohit,Seethapathy Harish,Gupta Shruti,Heller Howard M.,Wszolek Matthew,Steele David,Klepeis Veronica E.,Rennke Helmut,Sise Meghan E.
Funder
National Institutes of Health
National Kidney Foundation
Reference9 articles.
1. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017
2. The ileal neobladder: complications and functional results in 363 patients after 11 years of followup;Hautmann;J Urol,1999
3. Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution;Jin;Eur Urol,2012
4. ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion;Hautmann;Eur Urol,2013
5. The natural history of postoperative renal function in patients undergoing ileal conduit diversion for cancer measured using serial isotopic glomerular filtration rate and 99m technetium-mercaptoacetyltriglycine renography;Samuel;J Urol,2006